Galera Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
HOLMLUND JON T officer: Chief Medical Officer
Common Stock 2,059 $12 $24,710
Option
HOLMLUND JON T officer: Chief Medical Officer
Stock Option 2,059 $12 $24,710
Option
HOLMLUND JON T officer: Chief Medical Officer
Common Stock 2,059 $12 $24,710
Option
HOLMLUND JON T officer: Chief Medical Officer
Common Stock 1,489 $12 $17,868
Sale
HOLMLUND JON T officer: Chief Medical Officer
Common Stock 1,489 $12 $17,868
Option
HOLMLUND JON T officer: Chief Medical Officer
Stock Option 1,489 $12 $17,868
Option
HOLMLUND JON T officer: Chief Medical Officer
Common Stock 3,064 $1.07 $3,278
Sale
HOLMLUND JON T officer: Chief Medical Officer
Common Stock 3,064 $1.07 $3,278
Option
HOLMLUND JON T officer: Chief Medical Officer
Stock Option 3,064 $1.07 $3,278
Purchase
ALLEVA LAWRENCE M director
Common Stock 4,000 $9.79 $39,140
Purchase
BLACKSTONE CLARUS GP L.P. 10 percent owner
Common Stock 250,000 $12 $3,000,000
Purchase
CLARUS IV-A, L.P. 10 percent owner
Common Stock 250,000 $12 $3,000,000
Purchase
NEW ENTERPRISE ASSOCIATES 14, L.P. 10 percent owner
Common Stock 416,666 $12 $4,999,992
Purchase
NOVARTIS BIOVENTURES LTD other: Former 10% Owner
Common Stock 250,000 $12 $3,000,000
Purchase
NOVO HOLDINGS A/S 10 percent owner
COMMON STOCK 500,000 $12 $6,000,000
Purchase
SOFINNOVA VENTURE PARTNERS IX, L.P. 10 percent owner
Common Stock 750,000 $12 $9,000,000

Showing 100 to 116 of 116 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.